Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-01-31 22:15 |
Valneva Announces Initiation of Adolescent Phase 3 Trial for its Single-Shot Ch…
|
English | 418.0 KB | ||
| 2022-01-31 22:15 |
Valneva lance un essai de Phase 3 chez les adolescents pour son candidat vaccin…
|
French | 502.3 KB | ||
| 2022-01-25 18:15 |
Valneva Advances Booster Phase of Cov-Compare Trial of Its Inactivated COVID-19…
|
English | 390.7 KB | ||
| 2022-01-25 18:15 |
Valneva lance la phase de rappel de l’étude Cov-Compare avec son candidat vacci…
|
French | 407.7 KB | ||
| 2022-01-19 18:20 |
Le candidat vaccin inactivé de Valneva montre une neutralisation du variant Omi…
|
French | 412.4 KB | ||
| 2022-01-19 18:20 |
Valneva’s Inactivated COVID-19 Vaccine Candidate Shown to Neutralize Omicron Va…
|
English | 496.3 KB | ||
| 2022-01-06 08:30 |
VALNEVA Déclaration d’actions et de droits de vote - 31 décembre 2021
|
French | 359.2 KB | ||
| 2022-01-06 08:30 |
VALNEVA Declaration of shares and voting rights - December 31, 2021
|
English | 104.2 KB | ||
| 2022-01-06 07:00 |
Valneva confirme le calendrier des essais cliniques et des demandes d'autorisat…
|
French | 395.0 KB | ||
| 2022-01-06 07:00 |
Valneva Confirms Clinical Trial and Regulatory Submission Timelines for its Ina…
|
English | 315.3 KB | ||
| 2021-12-23 17:45 |
Valneva and Scottish Enterprise in Advanced Discussions for Major Grant to Comp…
|
English | 315.0 KB | ||
| 2021-12-23 17:45 |
Valneva et Scottish Enterprise en discussions avancées pour une importante subv…
|
French | 404.8 KB | ||
| 2021-12-21 19:05 |
Valneva annonce des résultats positifs pour l’essai d’homogénéité des lots clin…
|
French | 495.4 KB | ||
| 2021-12-21 19:05 |
Valneva Announces Positive Lot-to-Lot Consistency Trial Results for its Single-…
|
English | 324.2 KB | ||
| 2021-12-16 07:00 |
Valneva annonce des résultats positifs pour le rappel homologue de son candidat…
|
French | 514.6 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
